Download FREE Report Sample
Download Free sampleAnti?vascular Endothelial Growth Factor Therapy Market contains market size and forecasts of Anti?vascular Endothelial Growth Factor Therapy in Global, including the following market information:
Global Anti?vascular Endothelial Growth Factor Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anti?vascular Endothelial Growth Factor Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Extraction Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti?vascular Endothelial Growth Factor Therapy include Regeneron Pharmaceuticals (Eylea), Genentech and Kanghong Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti?vascular Endothelial Growth Factor Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti?vascular Endothelial Growth Factor Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anti?vascular Endothelial Growth Factor Therapy Market Segment Percentages, by Type, 2021 (%)
Extraction Injection
Precharge Injection
Global Anti?vascular Endothelial Growth Factor Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anti?vascular Endothelial Growth Factor Therapy Market Segment Percentages, by Application, 2021 (%)
Macular Degeneration
Nacular Edema
Uveitis
Retinal Vein Occlusion
Global Anti?vascular Endothelial Growth Factor Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anti?vascular Endothelial Growth Factor Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti?vascular Endothelial Growth Factor Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anti?vascular Endothelial Growth Factor Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Regeneron Pharmaceuticals (Eylea)
Genentech
Kanghong Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy